LYNDSIE THOMPSON: Open Payments
NPI 1306215017 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,662 in 114 payments from 15 companies in 2025. Trend: 2023 $1,139 · 2024 $2,183 · 2025 $2,662
Food & beverage: $2,662
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 31 | $729 |
| UCB, Inc. | 11 | $549 |
| ABBVIE INC. | 21 | $326 |
| Galderma Laboratories, L.P. | 15 | $259 |
| Novartis Pharmaceuticals Corporation | 13 | $231 |
| LEO Pharma Inc. | 9 | $196 |
| Organon LLC | 1 | $93 |
| Janssen Biotech, Inc. | 3 | $76 |
| GENZYME CORPORATION | 2 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $38 |
Products named: Zoryve, Bimzelx, SKYRIZI, NEMLUVIO, ADBRY, COSENTYX, NEXPLANON, TREMFYA.
Industry payments across UT — which companies pay providers there.
